Non-invasive ventilation in severe acute respiratory failure complicating Madelung’s disease: a case series and management review - Scorecard - MDSpire

Non-invasive ventilation in severe acute respiratory failure complicating Madelung’s disease: a case series and management review

  • By

  • Bruno Gomes

  • Antonio M. Esquinas

  • Fares N. Alwajeeh

  • June 4, 2026

  • 0 min

Share

Clinical Scorecard: Application of Non-Invasive Ventilation in Severe Acute Respiratory Failure Associated with Madelung’s Disease: A Case Series and Management Analysis

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with Madelung’s disease experiencing acute respiratory failure, particularly due to COVID-19 pneumonia.
Care Setting

Key Highlights

  • Non-invasive ventilation (NIV) was successfully used as a primary strategy for acute respiratory failure, leading to positive patient outcomes.
  • Challenges included managing bilateral pneumothoraxes and identifying obstructive sleep apnea, which required careful monitoring.
  • A proactive NIV-first approach is emphasized as a viable strategy in high-risk patients, with attention to potential complications.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Clinical Best Practices

          • Careful interface selection for NIV is crucial.
          • Vigilance for complications during NIV therapy is necessary.
          • Systematic screening for obstructive sleep apnea should be conducted.
          • Involve a multidisciplinary team for comprehensive patient management.

          Related Resources & Content

          Original Source(s)

          Non-invasive ventilation in severe acute respiratory failure complicating Madelung’s disease: a case series and management review

          • by Bruno Gomes, Antonio M. Esquinas, Fares N. Alwajeeh

          • June 4, 2026

          Related Content

          Assessment of Long-term Cardiovascular Health and Exercise Capacity in Athletes Post-COVID-19: Findings from the COSMO Study

          Optimizing drug combinations to resurrect the potency of failed antibody therapy against emerging COVID-19 variants using IDentif.AI

          SARS-CoV-2 infection complicated by acute longitudinally extensive transverse myelitis and pulmonary embolism: a case report